Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Elle, MD Biotechnologies has raised $1.1M to develop a new birth control method. The funding will support their first in-human clinical trial planned for this fall.
PRIVATEJul 23, 2026•7 days ago
Amount Raised
$1.1 Million
Round Type
Seed
OttawaManufacturingBiotechnologyHealth Care
Description
Elle, MD Biotechnologies has raised $1.1M. The company aims to develop a birth control that avoids problems of IUDs and other existing methods. Their Livv device is similar to a NuvaRing, inserted monthly to prevent pregnancy. They will use the funding for their first in-human clinical trial at The Ottawa Hospital if approved by Health Canada.
Company Information
Company
Elle MD Biotechnologies
Location
Ottawa, Ontario, Canada
About
Elle, MD Biotechnologies is a startup focused on developing innovative birth control solutions. Their Livv device is a silicone-and-copper product designed to be inserted monthly to prevent pregnancy, similar to the NuvaRing. The company aims to overcome the limitations associated with IUDs and traditional birth control methods. They are preparing for their first in-human clinical trial.
Predictive Intelligence
Strategic
ML-powered predictions for Elle MD Biotechnologies's next move
OttawaManufacturingBiotechnologyHealth Care